Analysis of Pfizer 2021

Analysis of Pfizer 2021

Pfizer Inc. is a leading pharmaceutical company that manufactures and markets products to treat various conditions ranging from cardiovascular, cancer, immune disorders, and even rare disorders. The company is also actively involved in manufacturing sterile injectable pharmaceuticals, active pharmaceutical ingredients (APIs), and biosimilars. This famous pharmaceutical company's product portfolio includes many generic and patented drugs and APIs.

The company recently bolstered its efforts to fight against the COVID-19 pandemic and launched the Pfizer-BioNTech COVID-19 vaccine. The US FDA granted Pfizer approval for emergency use of the vaccine to prevent the spread of the novel coronavirus infection in individuals 12 years and older. Apart from making waves with the COVID-19 vaccine, Pfizer also has many innovative vaccines in its portfolio, including for the prevention of pneumococcal disease, meningococcal disease, and many others. The company also has an advanced pipeline of vaccines focused on infectious diseases.

Aruvian Research presents Analysis of Pfizer, Inc. A complete and comprehensive analysis of Pfizer includes an overview of the industry the company operates in and the impact of the COVID-19 pandemic on the pharmaceutical industry.

Company analysis from Aruvian includes a history of Pfizer, a business segment analysis of the segments Pfizer operates through, a look at the organization structure of the company, its product pipeline, investment analysis, a geographical operating segments analysis, and how Pfizer has been working at the forefront during the COVID-19 pandemic are all analyzed comprehensively in this report.

The major competitors of Pfizer, namely AstraZeneca, Eli Lilly and Co., and Abbott Laboratories, are analyzed through a company profile, in-depth business segment analysis, a financial analysis, and SWOT analysis. An economic analysis of Pfizer is also presented through ratio analysis, profit and loss analysis, presentation of the company balance sheet, and much more.

A SWOT Framework Analysis of Pfizer completes this in-depth company analysis.


A. Executive Summary
B. Looking at the Industry
B.1 Industry Definition
B.2 Brief Profile of the Industry
B.3 Impact of Covid-19 on the Pharmaceutical Industry
B.4 Industry SWOT Analysis
C. Looking at Pfizer, Inc.
C.1 Company Profile
C.2 History of the Company
C.3 Pfizer and the COVID-19 Pandemic
C.4 Organizational Divisions
C.5 Profiling the Key Executives
C.6 Products & Services
D. Looking at Business
D.1 Business Segments
D.2 Investment Analysis
D.3 Product Pipeline
D.4 Geographical Segments
D.5 Company Subsidiaries
E. Pfizer: SWOT Framework Analysis
E.1 Strengths to Build Upon
E.2 Weaknesses to Overcome
E.3 Opportunities to Exploit
E.4 Threats to Overcome
F. Profiling the Competition
F.1 AstraZeneca
F.1.1 Corporate Profile
F.1.2 Business Segment Analysis
F.1.3 Financial Analysis
F.1.4 SWOT Analysis
F.2 Eli Lilly and Co.
F.2.1 Corporate Profile
F.2.2 Business Segment Analysis
F.2.3 Financial Analysis
F.2.4 SWOT Analysis
F.3 Abbott Laboratories
F.3.1 Corporate Profile
F.3.2 Business Segment Analysis
F.3.3 Financial Analysis
F.3.4 SWOT Analysis
G. Pfizer: Financial Analysis of the Company
G.1 Current Financials
G.2 Balance Sheet
G.3 Profit & Loss Statement
G.4 Ratio Analysis
H. Pfizer: Outlook
I. Glossary of Terms

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook